- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04680858
Impact of Digital Communication Assist Tools in Endoscopic Team Communication During COVID-19 (EndoCom)
Impact of Digital Enhanced Telecommunication for Team Communication in Endoscopic Procedures During COVID-19 Pandemic
Study Overview
Detailed Description
Optimal communication is crucial for team work in high class endoscopy. Team work is highly challenged by the COVID-19 pandemic. Necessary protective equipment as FFP-mask and face shields impair communication significantly. Digital enhanced approaches to maintain team communication during endoscopic procedures are mandatory not only in actual circumstances.
Materials and methods:A prospective, two-armed interventional study will be performed at an endoscopy unit at a tertiary center. 200 endoscopic examinations (EGD, colonoscopy, EUS, ERCP) were randomly assigned (1:1) to a group that was performed with DECT equipped endoscopy team or with standard communication. All examinations were performed under protective equipment. Primary outcome was rate of communication associated adverse events. Secondary outcomes included team subjectively perceived comfort with DECT enhanced communication during endoscopic work, duration of examinations, SAE.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ulm, Germany
- Universitätsklinikum Ulm
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Member of staff of the endoscopic team (Doctor, nurse)
Exclusion Criteria:
- Deafness
- significantly impaired hearing
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard Communication
Endoscopic procedures performed by skilled endoscopic team with standard communication (no headset)
|
|
|
Experimental: DECT enhanced Communication
Endoscopic procedures performed by skilled endoscopic team with enhanced communication tools ( DECT headset)
|
Use of a digital enhanced telecommunication headset for team communication
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Communication associated adverse events
Time Frame: From start to stop of endoscopic procedure
|
Adverse events arising from impaired communication by COVID-19 protection equipment
|
From start to stop of endoscopic procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Severe adverse events
Time Frame: From start to stop of endoscopic procedure
|
Severe adverse evatent, not arising from from impaired communication by COVID-19 protection equipment
|
From start to stop of endoscopic procedure
|
|
Subjective Comfort of DECT communication
Time Frame: From start to stop of endoscopic procedure
|
Subjectiveley perceived level of comfort using DECT communication during endoscopic procedures rated by numeric rating scale (1-6)
|
From start to stop of endoscopic procedure
|
|
Endoscopic time
Time Frame: From start to stop of endoscopic procedure
|
Duration of performed endoscopic procedures
|
From start to stop of endoscopic procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 122020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Communication
-
Shanghai Zhongshan HospitalNot yet recruitingICU | Eye Tracking | Communication Barriers | Non-Verbal Communication
-
Insel Gruppe AG, University Hospital BernSwiss National Science Foundation; University of Bern; Fachhochschule NordwestschweizRecruitingCommunication Research | Communication, MultidisciplinarySwitzerland, Austria
-
University of Wisconsin, MadisonUniversity of South Florida; University of Pittsburgh; University of Oklahoma; Duke... and other collaboratorsEnrolling by invitationCommunication Research | Communication ProgramsUnited States
-
Florida State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD); Duquesne...CompletedSocial CommunicationUnited States
-
The University of Tennessee, KnoxvilleNational Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruiting
-
The University of Tennessee, KnoxvilleNational Institute on Deafness and Other Communication Disorders (NIDCD)Completed
-
Bozok UniversityNot yet recruiting
-
Al-Hadba universityEnrolling by invitation
-
The University of Tennessee, KnoxvilleNational Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruitingTeacher Practice | Sign Language SkillsUnited States
-
Johns Hopkins UniversityCompletedCommunication | Obstetric Complication | High Risk Pregnancy | Multidisciplinary CommunicationUnited States
Clinical Trials on DECT
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMalignant Neoplasm | Metastatic Malignant Neoplasm in the BrainUnited States
-
Swiss Federal Institute of TechnologyCompleted
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
M.D. Anderson Cancer CenterActive, not recruitingCarcinoid Tumor | Carcinoid Syndrome | Metastatic Carcinoid Tumor | Digestive System Neuroendocrine Tumor G1United States
-
State University of New York - Upstate Medical...CompletedOsteoporosisUnited States
-
Duke UniversitySiemens Medical SolutionsTerminatedProstate Cancer | Dual Energy CT (DECT)United States
-
University of WashingtonCompleted
-
Advanced Bionics AGAdvanced BionicsCompletedHearing Loss, Binaural | Hearing Loss, MonauralSwitzerland
-
Ardea Biosciences, Inc.Completed
-
Lille Catholic UniversityAuckland UniversityActive, not recruiting